Drug
Cefprozil clinical trials
- studies test it
- 12
- open now
- 1
- in phase 3
- 0
- first study started
- 2003
Keep track of what changes. Save the Cefprozil studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2004 (6)
| Year | Studies |
|---|---|
| 2003 | 2 |
| 2004 | 6 |
| 2005 | 2 |
| 2018 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 9
- Phase 4
- 1
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 2
Teva Pharmaceuticals USA (4) · Sandoz (4) · Ranbaxy Laboratories Limited (2) · The Affiliated Hospital of Qingdao University (1) · Medical College of Wisconsin (1)
Often tested with
Tested in the same studies.
Ampicillin (1) · Ceftriaxone (1) · Amoxicillin (1) · Sulbactam (1) · Clavulanic Acid (1) · Clindamycin (1) · Levofloxacin (1)
Studies
Open first, then newest update. How each study uses Cefprozil is read from its arms, and is right about nine times in ten.
Testing it · 12
- Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAPRecruitingPhase 4Medical College of WisconsinNCT06494072Written as Cefprozil
- Cefprozil 500 mg Tablets Under Fed ConditionsCompletedPhase 1Teva Pharmaceuticals USANCT00840866Written as cefprozil
- Cefprozil 500 mg Tablets Under Fasting ConditionsCompletedPhase 1Teva Pharmaceuticals USANCT00840281Written as Cefzil® 500 mg tablets
- Cefprozil for Oral Suspension 250 mg/5 mL, FastingCompletedPhase 1Teva Pharmaceuticals USANCT00835614Written as Cefprozil for oral suspension 250 mg/5 mL
- Cefprozil for Oral Suspension 250 mg/5 mL, Non-fastingCompletedPhase 1Teva Pharmaceuticals USANCT00835354Written as Cefprozil for oral suspension 250 mg/5 mL
- Bioequivalence of Cefprozil Granule in Healthy Chinese VolunteersCompletedPhase 1The Affiliated Hospital of Qingdao UniversityNCT04414254Written as Cefprozil 125mg/5ml Susp; Cefprozil granule (125mg)
- To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fasting ConditionsCompletedPhase 1SandozNCT00881426Written as Cefprozil 500 mg Tablets (Sandoz GmbH)
- To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fed ConditionsCompletedPhase 1SandozNCT00881855Written as Cefprozil 500 mg Tablets (Sandoz, GmbH)
- To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Fed ConditionsCompletedPhase 1SandozNCT00881400Written as Cefprozil 250 mg/5 ml Oral Suspension (Sandoz, Austria)
- To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Following a 10 ml Dose Fasting Conditions.CompletedPhase 1SandozNCT00881153Written as Cefprozil 250 mg/5 ml Oral Suspension (Sandoz GmbH)
- Bioequivalence Study of Cefprozil Tablets, USP 500 mg Under Fasting ConditionsCompletedNot applicableRanbaxy Laboratories LimitedNCT00778778Written as cefprozil 500mg tablets
- Bioequivalence Study of Cefprozil Tablets, USP 500 mg Undef Fed ConditionsCompletedNot applicableRanbaxy Laboratories LimitedNCT00778245Written as cefprozil 500mg tablets
Codes
What other systems call Cefprozil · ClinicalTrials.gg INT006881
- MeSH (NLM) D000097670CefprozilConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 4W0459ZA4VCEFPROZILConfirmed FDA, NLM
- RxNorm 19552One source FDA
- NCI Thesaurus C28917CefprozilOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000097670 | Cefprozil | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 4W0459ZA4V | CEFPROZIL | Confirmed FDA, NLM |
| RxNorm | 19552 | — | One source FDA |
| NCI Thesaurus | C28917 | Cefprozil | One source FDA |
Also registered as cefprozil anhydrous (UNII 1M698F4H4E · RxNorm 1546020).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.